Guillain Barré Syndrome

Increase in Guillain-Barré Syndrome Following AstraZeneca COVID-19 Vaccine

Guillain-Barré syndrome. Credit: UCL A correlation between a first dose of the AstraZeneca vaccine and a small but significant rise in cases of the serious neurological condition Guillain-Barré syndrome, has been identified by University College London scientists, as part of an analysis of United Kingdom National Health Service (NHS) data. Scientists, however, say it remains …

Increase in Guillain-Barré Syndrome Following AstraZeneca COVID-19 Vaccine Read More »